Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 25/100

Failure Rate

0.0%

0 terminated/withdrawn out of 6 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

33%

2 trials in Phase 3/4

Results Transparency

0%

0 of 2 completed trials have results

Key Signals

Enrollment Performance

Analytics

Phase 2
4(66.7%)
Phase 4
2(33.3%)
6Total
Phase 2(4)
Phase 4(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (6)

Showing 6 of 6 trials
NCT07538674Phase 2Not Yet Recruiting

Peiyuan Guben Tongluo Ointment for Elderly Sarcopenia

Role: collaborator

NCT07504536Phase 2Not Yet Recruiting

Ning Shen Dan Xiang Gao Fang for Heart-Kidney Disharmony Insomnia

Role: collaborator

NCT07504562Phase 2Not Yet Recruiting

Knee Pain Ejiao Paste for Knee Osteoarthritis

Role: collaborator

NCT07478328Phase 2Not Yet Recruiting

Chaigui Longmu Ejiao Paste for Ischemic Heart Disease

Role: collaborator

NCT06175117Phase 4Completed

Clinical Study on the Treatment of Postpartum Anemia With Compound E Jiao Jiang(cEJJ）

Role: lead

NCT07270146Phase 4Completed

Effectiveness and Safety of Guilu Erxian Oral Liquid in the Treatment of Oligozoospermia and Asthenospermia With Syndrome of Shen (Kidney) Essence Deficiency

Role: lead

All 6 trials loaded